> Details

Rahm, Ann-Kathrin [Author]; Hackbarth, Juline [Author]; Müller, Mara Elena [Author]; Pfeiffer, Julia [Author]; Gampp, Heike [Author]; Petersenn, Finn [Author]; Rivinius, Rasmus [Author]; Frey, Norbert [Author]; Lugenbiel, Patrick [Author]; Thomas, Dierk [Author]

Differential effects of the Betablockers Carvedilol, Metoprolol and Bisoprolol on cardiac Kv4.3 (Ito) channel isoforms

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Differential effects of the Betablockers Carvedilol, Metoprolol and Bisoprolol on cardiac Kv4.3 (Ito) channel isoforms
  • Contributor: Rahm, Ann-Kathrin [Author]; Hackbarth, Juline [Author]; Müller, Mara Elena [Author]; Pfeiffer, Julia [Author]; Gampp, Heike [Author]; Petersenn, Finn [Author]; Rivinius, Rasmus [Author]; Frey, Norbert [Author]; Lugenbiel, Patrick [Author]; Thomas, Dierk [Author]
  • Published: 2023
  • Published in: International journal of molecular sciences ; 24(2023), 18, Artikel-ID 13842, Seite 1-16
  • Language: English
  • DOI: 10.3390/ijms241813842
  • Identifier:
  • Keywords: antiarrhythmic effects ; betablocker ; heart failure ; Ito ; Kv4.3
  • Origination:
  • Footnote: Veröffentlicht: 8. September 2023
    Im Titel sind der Buchstabe "v" und der Ausdruck "to" tiefgestellt
  • Description: Cardiac Kv4.3 channels contribute to the transient outward K+ current, Ito, during early repolarization of the cardiac action potential. Two different isoforms of Kv4.3 are present in the human ventricle and exhibit differential remodeling in heart failure (HF). Cardioselective betablockers are a cornerstone of HF with reduced ejection fraction therapy as well as ventricular arrhythmia treatment. In this study we examined pharmacological effects of betablockers on both Kv4.3 isoforms to explore their potential for isoform-specific therapy. Kv4.3 isoforms were expressed in Xenopus laevis oocytes and incubated with the respective betablockers. Dose-dependency and biophysical characteristics were examined. HEK 293T-cells were transfected with the two Kv4.3 isoforms and analyzed with Western blots. Carvedilol (100 µM) blocked Kv4.3 L by 77 ± 2% and Kv4.3 S by 67 ± 6%, respectively. Metoprolol (100 µM) was less effective with inhibition of 37 ± 3% (Kv4.3 L) and 35 ± 4% (Kv4.3 S). Bisoprolol showed no inhibitory effect. Current reduction was not caused by changes in Kv4.3 protein expression. Carvedilol inhibited Kv4.3 channels at physiologically relevant concentrations, affecting both isoforms. Metoprolol showed a weaker blocking effect and bisoprolol did not exert an effect on Kv4.3. Blockade of repolarizing Kv4.3 channels by carvedilol and metoprolol extend their pharmacological mechanism of action, potentially contributing beneficial antiarrhythmic effects in normal and failing hearts.
  • Access State: Open Access